March 13, 2019
Cravath represented Credit Suisse AG, Cayman Islands Branch as administrative agent in connection with the arrangement of $1.305 billion of senior secured credit facilities made available to Tivity Health, Inc., a provider of fitness and health improvement programs, to finance its acquisition of Nutrisystem, Inc., a commercial provider of weight loss products and services. The facilities consisted of a $1.18 billion term loan facility and a $125 million revolving credit facility. The transaction closed on March 8, 2019.
The Cravath team included partner Craig F. Arcella and associates Randall F. Limberg and Marc Bode on banking matters. Eugene Kim also worked on banking matters and Falguni Joshi worked on executive compensation and benefits matters.
Deals & Cases
February 13, 2025
On February 4, 2025, Marlin Equity Partners, a leading global investment firm, announced its acquisition of EIDO Healthcare, a leading provider of digital consent and patient information solutions. EIDO Healthcare will be combined with Radar Healthcare, an existing Marlin Equity Partners portfolio company and a provider of risk, quality, and compliance software for the healthcare and social care sectors. Cravath represented Marlin Equity Partners in the committed debt financing in connection with the transaction.
Deals & Cases
October 02, 2024
On September 25, 2024, Investcorp a leading global alternative investment firm, announced its acquisition of Stowe Family Law Holdings Limited, the largest specialist family law firm in the United Kingdom. Cravath represented Investcorp in the committed debt financing in connection with the transaction.
Deals & Cases
February 05, 2024
Cravath represented Artivion, Inc. in connection with $350 million of credit facilities obtained from Ares Management Credit funds to comprehensively address its debt maturities. Artivion is a medical device company focused on developing simple, elegant solutions that address cardiac and vascular surgeons’ most difficult challenges in treating patients with aortic diseases. The facilities consisted of a $190 million secured term loan facility, a $100 million secured delayed draw term loan facility and a $60 million secured revolving credit facility. The transaction closed on January 18, 2024.
Celebrating 200 years of partnership. In 2019, we celebrated our bicentennial. Our history mirrors that of our nation. Integral to our story is our culture.
Attorney Advertising. ©2025 Cravath, Swaine & Moore LLP.